GREGORY PARKER: Open Payments
NPI 1073574687 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,396 in 84 payments from 19 companies in 2025. Trend: 2023 $1,477 · 2024 $1,306 · 2025 $1,396
Food & beverage: $1,310Education: $86
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $226 |
| Lundbeck LLC | 9 | $158 |
| Novo Nordisk Inc | 10 | $146 |
| Sumitomo Pharma America, Inc. | 9 | $143 |
| GlaxoSmithKline, LLC. | 13 | $138 |
| Abbott Laboratories | 7 | $137 |
| Amgen Inc. | 5 | $87 |
| ABBVIE INC. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $54 |
Products named: REXULTI, GEMTESA, FREESTYLE LIBRE, Ozempic, BREZTRI, TRELEGY ELLIPTA, EVENITY, UBRELVY.
Industry payments across MS — which companies pay providers there.
